CY1113737T1 - TESTOSTERONIS IMPROVED GEL AND METHOD OF USE - Google Patents

TESTOSTERONIS IMPROVED GEL AND METHOD OF USE

Info

Publication number
CY1113737T1
CY1113737T1 CY20131100155T CY131100155T CY1113737T1 CY 1113737 T1 CY1113737 T1 CY 1113737T1 CY 20131100155 T CY20131100155 T CY 20131100155T CY 131100155 T CY131100155 T CY 131100155T CY 1113737 T1 CY1113737 T1 CY 1113737T1
Authority
CY
Cyprus
Prior art keywords
testosteronis
improved gel
improved
gel
hormone
Prior art date
Application number
CY20131100155T
Other languages
Greek (el)
Inventor
Ramana Malladi
Jodi Miller
Original Assignee
Unimed Pharmaceuticals, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06836341A external-priority patent/EP1937276B1/en
Application filed by Unimed Pharmaceuticals, Llc filed Critical Unimed Pharmaceuticals, Llc
Publication of CY1113737T1 publication Critical patent/CY1113737T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται σε μία βελτιωμένη διαδερμική σύσταση υδροαλκοολικής γέλης τεστοστερόνης που παρέχει, μεταξύ άλλων, επιθυμητό φαρμακοκινητικό προφίλ της ορμόνης, και σε μεθόδους χρήσεως.The present invention relates to an improved transdermal delivery of a testosterone hydroalcoholic gel that provides, inter alia, a desired pharmacokinetic profile of the hormone, and to methods of use.

CY20131100155T 2005-10-12 2013-02-20 TESTOSTERONIS IMPROVED GEL AND METHOD OF USE CY1113737T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72527605A 2005-10-12 2005-10-12
EP06836341A EP1937276B1 (en) 2005-10-12 2006-10-12 Improved testosterone gel and method of use

Publications (1)

Publication Number Publication Date
CY1113737T1 true CY1113737T1 (en) 2016-06-22

Family

ID=58448845

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100155T CY1113737T1 (en) 2005-10-12 2013-02-20 TESTOSTERONIS IMPROVED GEL AND METHOD OF USE

Country Status (1)

Country Link
CY (1) CY1113737T1 (en)

Similar Documents

Publication Publication Date Title
CY1120904T1 (en) IMPROVED TESTOSTERONE GEL AND METHOD OF USE IN THE TREATMENT OF HYPODONGISM
CY1124144T1 (en) COMPOSITIONS AND METHODS FOR TREATING CEREBRIAL EPISODE IN A SUBJECT ON CONCOMITANEOUS STATIN THERAPY
CY1118760T1 (en) MODIFIED ANTIBODIES AGAINST IL-23
CY1121672T1 (en) ANTIBODIES THAT BIND IL-17A AND IL-17F
CY1120384T1 (en) INDIVIDUAL THERAPEUTIC USEFUL IN TREATMENT OF ADDITIONAL DISORDERS
CY1115059T1 (en) THERAPEUTIC APPARATUS USEFUL IN THE THERAPEUTIC TREATMENT OF SUPPLEMENTARY DISORDERS
CY1115004T1 (en) PHARMACEUTICAL COMBINATIONS OF AN AGGIOTACIN RECEPTOR COMPONENTS AND A WATER INHIBITOR
TW200738270A (en) Method of treating depression using a TNFα antibody
DOP2006000277A (en) ANTI MN ANTIBODIES AND METHODS FOR USE
CY1115871T1 (en) METHODS FOR TREATMENT OF URINARY ARTHRITIS
CY1112798T1 (en) DIARYLIDOIN COMPOUNDS
EA200702643A1 (en) TWEAK ANTIBODIES
CY1119399T1 (en) ANTI-DKK-1 ANTIBODIES
CR9763A (en) USE OF A SINGLE DOSE OF SPECIFIC UNION MOLECULES CD20
CY1113314T1 (en) (3-Aryl-piperazin-1-yl) derivatives of 6,7-dialkoxycinazoline, 6,7-dialkoxyphalazine and 6,7-dialkoxysuccinoline
ATE474617T1 (en) MEDICAL DEVICE SYSTEMS
CY1115147T1 (en) ILL-17 SPECIALIZING EFFECTS OF HUMANITY
MA32349B1 (en) ANTAGONISTS OF THE HEDGEHOG PATHWAY BASED ON DISUBSTITUTED PHTALAZINES
CY1111579T1 (en) NEW COMBINED USE OF A SULFONAMIDE COMPOSITION IN CANCER TREATMENT
TR201821029T4 (en) Improved anti-IL-23p19 antibodies.
NO20075068L (en) Lipocalinprotein
CY1118968T1 (en) Increased bioavailability of active substance in naltrexone therapy
CY1116823T1 (en) ABCB5 TARGETING FOR CANCER TREATMENT
CY1120368T1 (en) Sequence of Specific Split MMR-14
ATE395082T1 (en) ANTIBODIES TO CANCER ANTIGEN TMEFF2 AND ITS APPLICATIONS